Concepedia

K. Yamazaki

KY

Statistics

Publications

5

Citations

354

H-Index

5

Active since

2007

Affiliations

Shizuoka Cancer Center(Current)

Kurashiki Central Hospital

Kyushu University

Yokohama City University

University of Occupational and Environmental Health Japan

K. Yamazaki is an author at Shizuoka Cancer Center specializing in oncology, gastrointestinal oncology, and medicine.

Publications per year

2007–2024

5

Publications

5

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

K. Yamazaki, Michitaka Nagase, H Tamagawa et al. · Annals of Oncology · 2016 · 282 citations · Full text

, , +8

Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY

Kozo Kataoka, Ken Mori, Yuichi Nakamura et al. · Annals of Oncology · 2024 · 34 citations

, , +17

Efficacy and Safety of an Irinotecan plus Bolus 5-Fluorouracil and L-Leucovorin Regimen for Metastatic Colorectal Cancer in Japanese Patients: Experience in a Single Institution in Japan

Takayuki Yoshino, Narikazu Boku, Yusuke Onozawa et al. · Japanese Journal of Clinical Oncology · 2007 · 14 citations · Full text

, , +14

Modified FOLFOX-6 Therapy for Heavily Pretreated Advanced Gastric Cancer Refractory to Fluorouracil, Irinotecan, Cisplatin and Taxanes: A Retrospective Study

Kunihiro Tsuji, Haruna Yasui, Yusuke Onozawa et al. · Japanese Journal of Clinical Oncology · 2012 · 14 citations · Full text

, , +14

O-11 Monitoring molecular residual disease by circulating tumor DNA in resectable colorectal cancer: Molecular subgroup analyses of a prospective observational study GALAXY in CIRCULATE-Japan

Hiromichi Shirasu, Hiroki Taniguchi, Junichiro Watanabe et al. · Annals of Oncology · 2021 · 10 citations · Full text

, , +17

1–5 of 5